Literature DB >> 9140456

Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature.

J A Bridge1, M Nelson, E McComb, M H McGuire, H Rosenthal, G Vergara, G E Maale, S Spanier, J R Neff.   

Abstract

Tumor-specific chromosomal abnormalities have been identified in several histologic subtypes of sarcomas. Characterization of recurrent chromosomal abnormalities has provided direction for molecular investigations of pathogenetically important genes. Cytogenetic reports of osteosarcoma, the most common primary malignant bone tumor, are relatively rare. In this study, 73 osteosarcoma specimens from 51 patients were cytogenetically analyzed following short-term culture. Clonal chromosomal abnormalities were detected in 47 and included one haploid specimen, 18 near-diploid specimens, 17 near-triploid, 8 near-tetraploid, 1 near-hexaploid, and 2 specimens with multiple clones of different ploidy levels. Examination of the present data and previously published data (111 clonally abnormal osteosarcoma specimens) reveals that chromosomal bands or regions 1p11-13, 1q10-12, 1q21-22, 11p15, 12p13, 17p12-13, 19q13, and 22q11-13 are most frequently rearranged and the most common numerical abnormalities are +1, -9, -10, -13, and -17. Partial or complete loss of the long arm of chromosome 6 also was seen in all cases of the present study and all previously published cases describing structural abnormalities of 6q. Parosteal osteosarcoma, a prognostically favorable osteosarcoma subtype, was characterized by the presence of a ring chromosome accompanied by no or few other abnormalities. Complex karyotypes were seen nearly exclusively in the high-grade lesions. These findings indicate that specific chromosomal bands and/or regions are nonrandomly involved in osteosarcoma and may provide useful clinical information.

Entities:  

Mesh:

Year:  1997        PMID: 9140456     DOI: 10.1016/s0165-4608(96)00306-8

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  32 in total

Review 1.  Soft tissue sarcomas with complex genomic profiles.

Authors:  Louis Guillou; Alain Aurias
Journal:  Virchows Arch       Date:  2010-02       Impact factor: 4.064

2.  Predictive properties of DNA methylation patterns in primary tumor samples for osteosarcoma relapse status.

Authors:  Jeremy M Rosenblum; N Ari Wijetunga; Melissa J Fazzari; Mark Krailo; Donald A Barkauskas; Richard Gorlick; John M Greally
Journal:  Epigenetics       Date:  2015-01-23       Impact factor: 4.528

3.  Evaluation of paediatric osteosarcomas by classic cytogenetic and CGH analyses.

Authors:  J R Batanian; L R Cavalli; N M Aldosari; E Ma; C Sotelo-Avila; M B Ramos; J D Rone; C M Thorpe; B R Haddad
Journal:  Mol Pathol       Date:  2002-12

Review 4.  Advancing therapy for osteosarcoma.

Authors:  Jonathan Gill; Richard Gorlick
Journal:  Nat Rev Clin Oncol       Date:  2021-06-15       Impact factor: 66.675

5.  Organization of the amplified type I interferon gene cluster and associated chromosome regions in the interphase nucleus of human osteosarcoma cells.

Authors:  Michael J Zeitz; Narasimharao V Marella; Kishore S Malyavantham; Sandra Goetze; Juergen Bode; Ivan Raska; Ronald Berezney
Journal:  Chromosome Res       Date:  2009-03-13       Impact factor: 5.239

6.  Molecular characterization of the pediatric preclinical testing panel.

Authors:  Geoffrey Neale; Xiaoping Su; Christopher L Morton; Doris Phelps; Richard Gorlick; Richard B Lock; C Patrick Reynolds; John M Maris; Henry S Friedman; Jeffrey Dome; Joseph Khoury; Timothy J Triche; Robert C Seeger; Richard Gilbertson; Javed Khan; Malcolm A Smith; Peter J Houghton
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

7.  Hypocalcemia in a patient with osteosarcoma and 22q11.2 deletion syndrome.

Authors:  Francis J Mussai; Lea C Cunningham; Geoffrey Rezvani; Constantine A Stratakis; James C Reynolds; Galina Nesterova; Robert M Henshaw; Jason E Levine; Lee J Helman; Diane C Arthur; Su Young Kim
Journal:  J Pediatr Hematol Oncol       Date:  2008-08       Impact factor: 1.289

8.  Establishment and cytogenetic characterization of a cell line from a pulmonary metastasis of osteosarcoma.

Authors:  Carolina Salinas-Souza; Indhira Dias Oliveira; Renato de Oliveira; Maria Teresa de Seixas Alves; Antonio Sergio Petrilli; Silvia Regina Caminada Toledo
Journal:  Cytotechnology       Date:  2012-07-26       Impact factor: 2.058

9.  Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas.

Authors:  Sébastien Salas; Catherine Bartoli; Jean-Laurent Deville; Jean Gaudart; Fréderic Fina; Arlette Calisti; Gérard Bollini; Georges Curvale; Jean-Claude Gentet; Florence Duffaud; Dominique Figarella-Branger; Corinne Bouvier
Journal:  Virchows Arch       Date:  2007-09-05       Impact factor: 4.064

10.  Down-regulation of ribosomal protein L7A in human osteosarcoma.

Authors:  Shui-er Zheng; Yang Yao; Yang Dong; Feng Lin; Hui Zhao; Zan Shen; Yuan-jue Sun; Li-na Tang
Journal:  J Cancer Res Clin Oncol       Date:  2009-01-06       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.